Member-only story

Solutions

The Dodo Bird: A De-extinction Challenge to Humanity’s Perception of Utility

Do we need it? Can we eat it? And what benefit will it provide to humans?

Kathryn Hamilton
Bioeconomy.XYZ
Published in
8 min readApr 28, 2023

--

Image from Colossal’s website; used with permission from the company.

Kathryn’s piece was first posted on the Colossal Biosciences blog and has been cross-posted on Bioeconomy.XYZ

In February of 2023, Colossal Biosciences announced its Series B funding. This funding round of $150M was a vote of financial confidence that the company was well on its way to achieving its scientific milestones and would continue to catalyze significant progress across the woolly mammoth and thylacine de-extinction projects as well as existing and planned conservation efforts. In conjunction with the funding, Colossal also announced the launch of its Avian Genomics Group. This group would focus on expanding humanity’s current understanding of the Aves class while also addressing major problems in birds–across de-extinction, conservation, and rewilding.

And it could not have come at a better time as there has been tremendous stress on bird populations around the world which have been surviving rampant parasitic infections, unknown diseases, and the worst outbreak of avian flu this century. And these stressors have not been isolated to bird populations as the avian flu has now been recorded as…

--

--

Bioeconomy.XYZ
Bioeconomy.XYZ

Published in Bioeconomy.XYZ

The Medium publication for biotechnology and everyone involved in the revolution. The best brought to you by the brightest.

Kathryn Hamilton
Kathryn Hamilton

Written by Kathryn Hamilton

Integrating Business with the Developing Bioeconomy // Making the Complex Uncomplicated

No responses yet